| Micro-laminin gene therapy can function as an inhibitor of muscle disease in the dyW mouse model of MDC1A D Packer, PT Martin Molecular Therapy-Methods & Clinical Development 21, 274-287, 2021 | 12 | 2021 |
| The history of the antibody as a tool D Packer Acta histochemica 123 (4), 151710, 2021 | 10 | 2021 |
| Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression … PT Martin, DA Zygmunt, A Ashbrook, S Hamilton, D Packer, SM Birch, ... PLoS One 16 (3), e0248721, 2021 | 9 | 2021 |
| A first-in-human phase I/IIa gene transfer clinical trial for Duchenne muscular dystrophy using rAAVrh74. MCK. GALGT2 KM Flanigan, TA Vetter, TR Simmons, M Iammarino, EC Frair, F Rinaldi, ... Molecular Therapy-Methods & Clinical Development 27, 47-60, 2022 | 8 | 2022 |
| Single cell analysis of AR N terminal, AR C terminal and the ARv7 splice variant in the CTCs of metastatic castration resistant prostate cancer (mCRPC) patients J Kelvin, D Lu, D Packer, R Bambury, D Rathkopf, N Schreiber, Z Arslan, ... Cancer Research 75 (15_Supplement), 1588-1588, 2015 | 6 | 2015 |
| Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration D Packer, EE Fresenko, EP Harrington Frontiers in Molecular Neuroscience 16, 2023 | | 2023 |
| Safety of Delivery of rAAVrh74. MCK. GALGT2 by Isolated Limb Infusion in Two Boys as a Surrogate Gene Therapy for Duchene Muscular Dystrophy KM Flanigan, T Vetter, E Frair, A Bradley, J Harris, T Simmons, D Packer, ... MOLECULAR THERAPY 29 (4), 292-292, 2021 | | 2021 |
| Leveraging the Extracellular Matrix to Create Novel Gene Therapies for the Congenital Muscular Dystrophies DR Packer The Ohio State University, 2021 | | 2021 |
| A New Laminin a2-Based Gene Therapy for Congenital Muscular Dystrophy 1A D Packer, PT Martin MOLECULAR THERAPY 28 (4), 219-219, 2020 | | 2020 |
| 444 Presence of AR-V7 splice variant or AR C terminal loss in the CTCs of mCRPC patients identifies patients with improved PSA response with taxanes over androgen receptor … HI Scher, J Kelvin, D Lu, J Louw, D Packer, R Bambury, D Rathkopf, ... European Journal of Cancer 3 (51), S93, 2015 | | 2015 |
